University of New Hampshire · 4 hours ago
Learning Researcher - Bioprinting Stem Cells
The University of New Hampshire is an R1 Carnegie classification research institution, and they are seeking a Learning Researcher to work in Dr. Won Hyuk Suh's lab. The role involves guided research on developing novel bioprinting methodologies for producing human stem cell-based organoids optimized for pharmacological screening.
Career PlanningEducation
Responsibilities
The Suh Lab research projects focus on developing novel bioprinting methodologies for producing human stem cell-based organoids optimized for pharmacological screening
Qualification
Required
Faculty recommendation is required
Student will need to have prior or current tissue culture or qPCR experience
Ability to work up to 20 hours per week, as needed
Willingness to work during summer and winter breaks, as requested by their Principal Investigator
This position will require handling materials including bio- and chemical hazardous materials, hazardous wastes, sharps materials, extreme temperature materials, materials ≤ 40 lbs. Training is provided as required for safety in workplace operations
Applicants must be able to dawn appropriate Personal Protective Equipment (PPE) as related to and required by their duties
Preferred
Undergraduate or graduate student in a Life Sciences degree is preferred. Ideal candidates will be able to continue with this position long-term, over multiple semesters
Company
University of New Hampshire
University of New Hampshire is a school that offers undergraduate, graduate, and doctoral programs across a range of academic disciplines.
H1B Sponsorship
University of New Hampshire has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (34)
2023 (21)
2022 (26)
2021 (18)
2020 (13)
Funding
Current Stage
Late StageTotal Funding
$2.76MKey Investors
Centers for Disease Control and PreventionUS Department of Commerce, Economic Development Administation
2022-11-30Grant· $1.8M
2020-09-16Grant· $0.6M
2018-05-27Grant· $0.36M
Leadership Team
Recent News
2026-01-24
2025-06-02
Providence Business News
2025-06-01
Company data provided by crunchbase